These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 3958966)

  • 1. Comparative electropharmacology of mexiletine, lidocaine and quinidine in a canine Purkinje fiber model.
    Burke GH; Loukides JE; Berman ND
    J Pharmacol Exp Ther; 1986 Apr; 237(1):232-6. PubMed ID: 3958966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological actions of mexiletine (Kö1173) on canine Purkinje fibres and ventricular muscle.
    Arita M; Goto M; Nagamoto Y; Saikawa T
    Br J Pharmacol; 1979 Sep; 67(1):143-52. PubMed ID: 497518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency-dependent interactions of mexiletine and quinidine on depolarization and repolarization in canine Purkinje fibers.
    Roden DM; Iansmith DH; Woosley RL
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1218-24. PubMed ID: 2447269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide.
    Nattel S; Bailey JC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo.
    Costard-Jäckle A; Franz MR
    J Pharmacol Exp Ther; 1989 Oct; 251(1):39-46. PubMed ID: 2795468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of simultaneous administration of mexiletine and quinidine on the electrophysiologic parameters of canine Purkinje fibers.
    Burke GH; Loukides JE; Berman ND
    J Cardiovasc Pharmacol; 1986; 8(6):1138-43. PubMed ID: 2434738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of mexiletine (Kö1173) on ovine cardiac Purkinje fibers.
    Weld FM; Bigger JT; Swistel D; Bordiuk J; Lau YH
    J Pharmacol Exp Ther; 1979 Aug; 210(2):222-8. PubMed ID: 458628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval-dependent effects of lidocaine on conduction in canine cardiac Purkinje fibers: experimental observations and theoretical analysis.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):275-81. PubMed ID: 3572789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of antiarrhythmic drugs on the premature action potential duration in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Pharmacol Exp Ther; 1985 May; 233(2):304-11. PubMed ID: 3999021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of quinidine on the transmembrane potentials of young and adult canine cardiac Purkinje fibers.
    Morikawa Y; Rosen MR
    J Pharmacol Exp Ther; 1986 Mar; 236(3):832-7. PubMed ID: 3950873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cellular electropharmacology of mexiletine combined with sotalol in porcine papillary muscle and Purkinje fibre. II. Effects on action potential duration and refractoriness.
    Berman ND; Wang LY; Ahmed A
    Can J Cardiol; 1990 Nov; 6(9):423-30. PubMed ID: 2177360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophysiologic effects of halothane and quinidine on canine Purkinje fibers: evidence for a synergistic interaction.
    Gallagher JD; Gessman LJ; Moura P; Kerns D
    Anesthesiology; 1986 Sep; 65(3):278-85. PubMed ID: 3752573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential electrophysiologic effects of mexiletine on normal and hypoxic canine Purkinje fibers.
    Burke GH; Berman ND
    J Cardiovasc Pharmacol; 1985; 7(6):1096-100. PubMed ID: 2418294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery from use-dependent block of Vmax and restitution of action potential duration in canine cardiac Purkinje fibers.
    Elharrar V
    J Pharmacol Exp Ther; 1988 Jul; 246(1):235-42. PubMed ID: 3392655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mexiletine in isolated tissue models.
    Williams EM
    Postgrad Med J; 1977; 53 Suppl 1():30-4. PubMed ID: 876951
    [No Abstract]   [Full Text] [Related]  

  • 18. Disopyramide phosphate: is it just another quinidine.
    Kus T; Sasyniuk BI
    Can J Physiol Pharmacol; 1978 Apr; 56(2):326-31. PubMed ID: 638888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-dependent electrophysiological effects of quinidine and lidocaine on canine cardiac purkinje fibers.
    Nattel S; Elharrar V; Zipes DP; Bailey JC
    Circ Res; 1981 Jan; 48(1):55-61. PubMed ID: 7438346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.